Gene Solutions, one of Asia’s leading innovators in genetic testing, has joined hands with AMPATH (American Institute of Pathology and Laboratory Sciences), a trusted diagnostic services provider in India, to establish a state-of-the-art genomics laboratory in Hyderabad. This collaboration aims to expand access to high-value next-generation sequencing (NGS) technologies, making them more accessible to patients and healthcare providers across India.
Dr. Nguyen Hoai Nghia, Co-founder and CEO of Gene Solutions (sixth from left), and Dr. Maneesh Bagai, COO of AMPATH (standing to his right), formalized the partnership with the signing of a Memorandum of Understanding (MOU).
Integrating Genomics into Routine Diagnostics
By combining AMPATH’s extensive diagnostic footprint with Gene Solutions’ expertise in genomics, the partnership will enable earlier, more accurate, and more accessible testing in key clinical areas including reproductive health, cancer detection, and precision medicine.
AMPATH’s nationwide infrastructure—comprising over 20 satellite laboratories and more than 2,000 collection centers—provides a strong foundation to integrate genomics into everyday diagnostics. Through this network, the Hyderabad-based NGS lab will introduce advanced solutions such as:
triSure NIPT – A comprehensive non-invasive prenatal test that screens for chromosomal conditions, microdeletions, and selected single-gene disorders, offering expectant parents safer, earlier insights into fetal health and maternal well-being.
SPOT-MAS – A cutting-edge, clinically validated early cancer screening test capable of detecting signals from 75 cancer types and subtypes with a single blood sample, giving physicians a powerful tool for early intervention.
K-TRACK, K-4CARE – Multi-omics powered solutions for cancer monitoring and genomic profiling, helping oncologists personalize treatment strategies and detect recurrence with greater precision.
Driving Better Clinical Outcomes
The collaboration brings advanced genomic diagnostics into clinical practice, empowering healthcare professionals to make more informed decisions. Key benefits include:
Safer prenatal care – Providing families with early and accurate insights into maternal and fetal health.
Earlier cancer detection – Identifying major cancers such as breast, lung, colorectal, and head & neck cancers through a simple blood test.
Personalized oncology – Supporting oncologists in tailoring therapies and monitoring recurrence non-invasively.
A Shared Commitment to Accessible Precision Medicine
“This partnership reflects a shared vision—making high-quality, science-driven genetic testing more widely available,” said Dr. Nguyen Hoai Nghia, Co-founder and CEO of Gene Solutions. “We believe that technology should be inclusive. Working with AMPATH allows us to deliver advanced solutions through a familiar and trusted healthcare network.”
Dr. Maneesh Bagai, COO of AMPATH, added: “We are thrilled to expand into next-generation sequencing through this strategic alliance. Together, we are redefining what's possible in diagnostics—whether it's in maternal health, early cancer detection, or personalized oncology with patient centric approach.”